ID: ALA2287955

Max Phase: Preclinical

Molecular Formula: C11H14ClN5O2

Molecular Weight: 283.72

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1cc(CN2CCN/C2=N\[N+](=O)[O-])cnc1Cl

Standard InChI:  InChI=1S/C11H14ClN5O2/c1-2-9-5-8(6-14-10(9)12)7-16-4-3-13-11(16)15-17(18)19/h5-6H,2-4,7H2,1H3,(H,13,15)

Standard InChI Key:  UNFPDPNGIKETHR-UHFFFAOYSA-N

Associated Targets(non-human)

Periplaneta americana 513 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 283.72Molecular Weight (Monoisotopic): 283.0836AlogP: 1.25#Rotatable Bonds: 4
Polar Surface Area: 83.66Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.31CX LogP: 1.49CX LogD: 1.49
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.51Np Likeness Score: -0.85

References

1. Nishimura K, Kiriyama K, Kagabu S.  (2006)  Quantitative structureactivity relationships of imidacloprid and its analogs with substituents at the C5 position on the pyridine ring in the neuroblocking activity,  31  (2): [10.1584/jpestics.31.110]

Source